Cite
Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.
MLA
Qiaoli Zheng, et al. “Single Nucleotide Polymorphisms in Apoptosis Pathway Are Associated with Response to Imatinib Therapy in Chronic Myeloid Leukemia.” Journal of Translational Medicine, vol. 14, Mar. 2016, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12967-016-0837-5.
APA
Qiaoli Zheng, Jiang Cao, Hamad, N., Hyeoung-Joon Kim, Joon Ho Moon, Sang Kyun Sohn, Chul Won Jung, Lipton, J. H., Dong Hwan Kim, D., Zheng, Q., Cao, J., Kim, H.-J., Moon, J. H., Sohn, S. K., Jung, C. W., & Kim, D. D. H. (2016). Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia. Journal of Translational Medicine, 14, 1–11. https://doi.org/10.1186/s12967-016-0837-5
Chicago
Qiaoli Zheng, Jiang Cao, Nada Hamad, Hyeoung-Joon Kim, Joon Ho Moon, Sang Kyun Sohn, Chul Won Jung, et al. 2016. “Single Nucleotide Polymorphisms in Apoptosis Pathway Are Associated with Response to Imatinib Therapy in Chronic Myeloid Leukemia.” Journal of Translational Medicine 14 (March): 1–11. doi:10.1186/s12967-016-0837-5.